Regional bank Provident Financial Services (NYSE:PFS) rose by 5.8% on Thursday after Raymond James initiated coverage on the ...

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's ...

Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...

Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...

Gain 2x leveraged exposure to HIMS with HIMZ, ideal for high-risk traders. Read more on how to navigate recent volatility and ...

Intrusion Inc. (INTZ) closed the most recent trading day at $2.23, moving -5.51% from the previous trading session. This move ...

In the latest trading session, Amerigo Resources (ARREF) closed at $1.56, marking a -3.69% move from the previous day. The ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Detailed price information for Berkshire Hathaway Cl B (BRK-B-N) from The Globe and Mail including charting and trades.

Align Technology’s ALGN successful efforts to broaden the Invisalign business are poised to bring significant growth in the upcoming quarters. Also, iTero is gaining from the rapidly evolving ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

Advanced Micro Device shares have gained 18.9% year to date, outperforming the broader Zacks Computer & Technology sector’s ...